what would you tell week-1 you about non-peptide
Question in the title, detail here: what would you tell week-1 you about non-peptide. Nothing containing this compound is approved by any regulator, and research-use-only material is not approved for human use. Read both programme names carefully after mixing them up in a comment and being politely corrected. The…
Oral semaglutide is a peptide co-formulated with an absorption enhancer and carries food and water timing requirements. A small molecule does not have that constraint, which is the practical distinction.
Phase 2 or phase 3?
Daily dosing, so what does the exposure profile look like across the day?
Correction: that is the oral peptide product, which is a different thing entirely. This one is a small molecule.
do not assume reconstitution intuitions apply, there is nothing to reconstitute
daily dosing, not weekly, so the exposure profile is different
the tolerability profile reads broadly similar to the class
Careful — purity methods for peptides do not read across to a small molecule and the numbers are not equivalent.